Early Stage Large B-cell Lymphoma in the Rituximab-CHOP +/- Radiation Era: Tailored Therapy Provides Excellent Outcome
S. Dhakal(Bir Hospital), Louis S. Constine(University of Rochester Medical Center), Jonathan W. Friedberg(University of Rochester), Faith Young(University of Rochester), Richard I. Fisher(University of Rochester), Manzurul A. Sikder(University of Rochester), Steven H. Bernstein(University of Rochester), Jennifer L. Kelly(Oslo University Hospital)
International Journal of Radiation Oncology*Biology*Physics
October 5, 2009
Cited by 0
Related Papers
The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma
|New England Journal of Medicine|2002|3.9k
Stromal Gene Signatures in Large-B-Cell Lymphomas
|New England Journal of Medicine|2008|1.8k
Oncogenically active MYD88 mutations in human lymphoma
|Nature|2010|1.5k